Mankind Pharma Ltd.

BSE: 543904 | NSE: MANKIND |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE634S01028 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Mankind Pharma Mankind Pharma Ltd. | BSE 2258.75 15.50 (0.69%) | NSE 2258.90 17.00 (0.76%) | Trade | Add

BSE Live

Nov 26, 16:01

2258.75 15.50 (0.69%)

Volume

AVERAGE VOLUME

5-Day

23,200

10-Day

23,982

30-Day

25,051

16,285

Prev. Close

2243.25
Open Price

2266.50

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Nov 26, 15:57

2258.90 17.00 (0.76%)

Volume

AVERAGE VOLUME

5-Day

462,327

10-Day

559,087

30-Day

795,408

591,887

Prev. Close

2241.90
Open Price

2250.10

Bid Price (Qty.)
2258.90 (13)
Offer Price (Qty.)
0.00 (0)

Financials

Print/Copy to Excel : Go

Balance Sheet of Mankind Pharma (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	41.26	40.06	40.06	40.06	40.06
Total Share Capital	41.26	40.06	40.06	40.06	40.06
Reserves and Surplus	14,291.13	9,299.84	7,395.16	6,115.17	4,681.94
Total Reserves and Surplus	14,291.13	9,299.84	7,395.16	6,115.17	4,681.94
Total Shareholders Funds	14,332.39	9,363.09	7,435.22	6,155.23	4,722.00
Minority Interest	235.79	212.70	188.07	161.08	140.89
NON-CURRENT LIABILITIES
Long Term Borrowings	5,526.19	24.87	23.15	52.18	62.18
Deferred Tax Liabilities [Net]	1,812.51	89.07	77.31	55.62	13.03
Other Long Term Liabilities	34.03	30.68	30.67	20.15	8.89
Long Term Provisions	155.06	123.12	97.89	80.00	72.24
Total Non-Current Liabilities	7,527.79	267.74	229.02	207.96	156.35
CURRENT LIABILITIES
Short Term Borrowings	2,956.84	171.17	139.49	820.89	178.48
Trade Payables	1,133.40	1,102.99	1,008.18	1,076.38	666.97
Other Current Liabilities	909.45	456.26	407.84	461.70	273.73
Short Term Provisions	663.87	389.31	307.63	264.50	234.22
Total Current Liabilities	5,663.56	2,119.73	1,863.14	2,623.47	1,353.40
Total Capital And Liabilities	27,759.53	11,963.25	9,715.45	9,147.74	6,372.63
ASSETS
NON-CURRENT ASSETS
Tangible Assets	2,907.87	2,936.91	2,529.17	1,725.14	1,625.58
Intangible Assets	9,604.03	1,588.34	1,701.46	1,842.61	18.43
Capital Work-In-Progress	306.13	207.09	493.19	669.87	371.62
Fixed Assets	13,337.57	4,807.04	4,780.78	4,269.22	2,015.95
Non-Current Investments	351.09	309.81	270.95	235.01	205.80
Deferred Tax Assets [Net]	107.89	80.40	29.78	39.29	49.01
Long Term Loans And Advances	0.00	0.00	0.00	0.03	0.07
Other Non-Current Assets	482.08	177.76	286.05	176.93	174.71
Total Non-Current Assets	20,771.26	5,395.03	5,387.58	4,740.92	2,466.00
CURRENT ASSETS
Current Investments	1,690.84	2,258.11	1,075.47	874.46	1,306.17
Inventories	2,093.71	1,553.46	1,498.46	1,760.24	1,183.54
Trade Receivables	1,538.34	848.28	576.42	388.17	330.61
Cash And Cash Equivalents	554.50	1,197.97	453.20	405.94	700.74
Short Term Loans And Advances	3.95	2.86	1.63	1.19	18.41
OtherCurrentAssets	1,106.93	707.54	722.69	976.82	367.16
Total Current Assets	6,988.27	6,568.23	4,327.87	4,406.82	3,906.64
Total Assets	27,759.53	11,963.25	9,715.45	9,147.74	6,372.63
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	5,304.33	329.78	167.78	211.93	183.16
BONUS DETAILS
Bonus Equity Share Capital	0.52	0.52	0.52	0.52	0.52
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	160.19	120.52	0.00	0.00	0.00
Non-Current Investments Unquoted Book Value	0.00	0.00	89.54	235.01	205.40
CURRENT INVESTMENTS
Current Investments Quoted Market Value	1,690.84	2,258.11	1,075.47	874.46	0.00
Current Investments Unquoted Book Value	0.00	0.00	0.00	0.00	1,306.17